Current and future treatment of HIV infection.
Publication
, Journal Article
Bartlett, JA
Published in: Oncology (Williston Park)
November 1990
After much frustration in the last decade, HIV therapeutics is an emerging discipline. Over the past few years a number of new agents have been evaluated, including such antiviral drugs as zidovudine, dideoxycytidine and dideoxyinosine, and immunomodulators such as alpha interferon and interleukin-2. The author discusses these and other agents and the prospects for combination therapy.
Duke Scholars
Published In
Oncology (Williston Park)
ISSN
0890-9091
Publication Date
November 1990
Volume
4
Issue
11
Start / End Page
19 / 29
Location
United States
Related Subject Headings
- Zidovudine
- Humans
- HIV Infections
- Forecasting
- Antiviral Agents
- Adjuvants, Immunologic
Citation
APA
Chicago
ICMJE
MLA
NLM
Bartlett, J. A. (1990). Current and future treatment of HIV infection. Oncology (Williston Park), 4(11), 19–29.
Bartlett, J. A. “Current and future treatment of HIV infection.” Oncology (Williston Park) 4, no. 11 (November 1990): 19–29.
Bartlett JA. Current and future treatment of HIV infection. Oncology (Williston Park). 1990 Nov;4(11):19–29.
Bartlett, J. A. “Current and future treatment of HIV infection.” Oncology (Williston Park), vol. 4, no. 11, Nov. 1990, pp. 19–29.
Bartlett JA. Current and future treatment of HIV infection. Oncology (Williston Park). 1990 Nov;4(11):19–29.
Published In
Oncology (Williston Park)
ISSN
0890-9091
Publication Date
November 1990
Volume
4
Issue
11
Start / End Page
19 / 29
Location
United States
Related Subject Headings
- Zidovudine
- Humans
- HIV Infections
- Forecasting
- Antiviral Agents
- Adjuvants, Immunologic